BioAgilytix Revenue and Competitors
Estimated Revenue & Valuation
- BioAgilytix's estimated annual revenue is currently $262.6M per year.
- BioAgilytix received $Undisclosed in venture funding in June 2013.
- BioAgilytix's estimated revenue per employee is $248,000
- BioAgilytix's total funding is $30.1M.
Employee Data
- BioAgilytix has 1059 Employees.
- BioAgilytix grew their employee count by 0% last year.
BioAgilytix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31800M | 109578 | 4% | $367M | $146B |
What Is BioAgilytix?
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina's Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP. BioAgilytix's team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 23 of the top 25 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
$30.1M
Total Funding
1059
Number of Employees
$262.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioAgilytix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Director, DMPK | Reveal Email/Phone |
2 | VP, Quality Assurance | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Director, Bioanalytical / Formulation Chemistry | Reveal Email/Phone |
5 | Director, Project Services | Reveal Email/Phone |
6 | Senior Director, Business Development | Reveal Email/Phone |
7 | Director, Gene and Cell Therapy | Reveal Email/Phone |
8 | Medical Technologist III | Reveal Email/Phone |
9 | Sr. Director, Strategic Accounts | Reveal Email/Phone |
10 | VP and General Manager | Reveal Email/Phone |
BioAgilytix News
KG, ARUP Laboratories, BioAgilytix Labs, Copley Scientific Ltd., Distek Inc., Fluke Biomedical, Mayo Foundation for Medical Education and...
Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 ...
DURHAM, N.C., Aug. 18, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement t ...
SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- MicroConstants, Inc., a leader in bioanalytical testing services, announced that it has signed an agreement with BioAgilytix Labs, a leading global contract research organization (CRO) focused on supporting its pharmaceutical and biotech partners in all ...
Mr. Datin, age 56, currently serves as the President and Chief Executive Officer of BioAgilytix, LLC, a global bioanalytical contract research ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $536.7M | 1086 | N/A | N/A |
#2 | $276.9M | 1099 | N/A | N/A |
#3 | $234.7M | 1132 | 2% | $25M |
#4 | $236.1M | 1163 | 4% | N/A |
#5 | $166.9M | 1169 | 5% | N/A |
BioAgilytix Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2013-06-05 | $Undisclosed | Undisclosed | Riverside Partners | Article |
BioAgilytix Executives
| Name | Title |
|---|---|
| Dominic Marasco | Chief Commercial Officer |
| Jim McNally | Chief Scientific Officer |
| Euan Menzies | Chairman and CEO |
| Thomas Zajkowski | Chief Financial Officer |
| Steve Michael | Chief Operating Officer |
| Arno Kromminga | Chief Scientific Advisor |
| Mark Bethers | Chief Of Staff |
| Christie Mabry | Chief People Officer |
| Steven Michael | Senior Vice President & Chief Operating Officer |
| Nathan Speicher | Chief Financial Officer |
| Kathryn Lindley | Vice President, Operations |
| Jose Buenviaje | Vice President, Quality Assurance |
| Linda Robbie | VP & GM, Boston Operations |
| Dominique Gouty | Senior Vice President Business Operations |
| David Williams | Vice President and General Manager |
| Chad Briscoe | Vice President Of Business Development Europe |
| Anita Simkins | Senior Vice President, Quality Assurance |
| Daniel Brooks | VP, Operational Excellence |
| Beth Heinz | Vice President, Business Development |
| Stephanie Girard | Vice President, Large Molecule Bioanalysis at BioAgilytix San Diego |
| Kennon Broadhurst | Vice President Global Marketing |
| Marc Westermann | Vice President of Business Development Europe |
| Kara Harrison | Vice President Global Quality Assurance |
| Dave Beyerlein | Vice President & General Manager, BioAgilytix San Diego |
| Alistair Draffan | Executive Vice President, Business Operations |
| Angela Luttick | Executive Vice President, Commercial |
| Steven Michael | Senior Vice President & Chief Operating Officer |
| Melinda Pryor | EVP, Scientific Operations |